Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 923 of 5804
-
New malaria drug combo shows promise in kids
Disease control OngoingSingle-center phase II/III clinical investigation of the pharmacokinetics and pharmacodynamics of artemether-lumefantrine and dihydroartemisinin-piperaquine for gametocyte clearance and post-treatment chemoprotection in Zambian children with uncomplicated falciparum malaria.
Phase: PHASE2, PHASE3 • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could hepatitis C-Positive kidneys be safe for transplant?
Disease control OngoingThis is an open-label, pilot trial to test the safety and efficacy of transplantation of kidneys from hepatitis C seropositive non-viremic (HCV Ab+/NAT-) and HCV seropositive viremic (HCV Ab+/NAT+) donors to HCV seronegative recipients on the kidney transplant waitlist. Treatment…
Phase: PHASE2 • Sponsor: Amit D Tevar, MD • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Diabetes drug metformin tested for fragile x symptoms
Symptom relief CompletedThis study is a controlled trial of metformin in individuals with fragile X syndrome between the ages of 6 and 35 years. Participants will be randomized in a double-blind design to either drug or placebo and will attend three visits to the study site in a 4-month period for a ser…
Phase: PHASE2 • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Shorter radiation may be as safe for High-Risk prostate cancer
Disease control OngoingThis is a phase 2 randomized study for High risk localized prostate cancer (T3 to T4 disease and/or PSA \> 20 and/or Gleason score ≥ 8) without evidence of distant and nodal metastasis. Patient will be randomized to:Arm 1 * Conventional IMRT RapidArc IMRT to prostate and pelvic…
Phase: PHASE2 • Sponsor: CCTU • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Needle instead of scalpel: new sperm retrieval method tested
Disease control OngoingThe objective of this study is to use ultrasound-guided rete testis flushing and aspiration technique to retrieve sperm, non-surgically, from the testes of azoospermic men. If sperm are retrieved by this method, it will provide a direct benefit to the infertile men. This protocol…
Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Immunotherapy-Ablation combo shows promise in early liver cancer trial
Disease control CompletedThis is a multicenter, single arm, prospective, open-label phase II trial investigating the clinical activity of peri-interventional treatment with the anti-PD1 antibody pembrolizumab in HCC patients who are candidates for local ablation via either radiofrequency ablation (RFA) o…
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Immunotherapy tackles precancerous mouth spots
Disease control Recruiting nowThis phase II pilot trial studies how well pembrolizumab works in treating leukoplakia. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Epigenetic drugs aim to stop cancer return after transplant in kids
Disease control OngoingThe objective of this study is to evaluate the maximum tolerated (MTD) of vorinostat used in combination with low-dose azacitidine after allogeneic hematopoietic cell transplantation (alloHCT) for prevention of relapse of childhood myeloid malignancies.
Phase: PHASE1 • Sponsor: Johns Hopkins All Children's Hospital • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New study challenges safety of keyhole surgery for cervical cancer
Disease control OngoingCervical cancer is the most common cause of death from gynecological cancer world-wide. With technological innovation, minimally invasive or even non-invasive medical treatment has become a trend. Since the first cases of laparoscopic radical hysterectomy of cervical cancer have …
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New hope for kids on dialysis: drug targets hormone imbalance
Disease control Recruiting nowThis is a phase 3 trial of etelcalcetide in pediatric participants with secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD) on hemodialysis.
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Robot therapy could speed stroke recovery in first months
Symptom relief Recruiting nowEarly after stroke, patients often have significant motor impairment and sensory deficit. Evidence has demonstrated heightened plasticity and significant recovery in the acute phase (first months) post stroke but there has been a lack of effective and practical protocols and devi…
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Cancer drug shows promise for treating lewy body dementia
Disease control CompletedThis study evaluates the effect of Bosutinib (Bosulif,Pfizer®) in the treatment of patients with Dementia with Lewy Bodies. Half participants will receive 100 mg of Bosutinib , while the other half will receive placebo.
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Immunotherapy combo tested for aggressive breast cancer – trial stopped early
Disease control TerminatedThis randomized phase III trial studies how well paclitaxel, trastuzumab, and pertuzumab with or without atezolizumab works in treating patients with breast cancer that has spread to other parts of the body (metastatic). Chemotherapy drugs, such as paclitaxel, work in different w…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo shot may slash opioid use after hernia repair
Symptom relief CompletedThis is a Phase 3b, open-label study to assess postoperative opioid use in subjects undergoing unilateral open inguinal herniorrhaphy with intraoperative administration of HTX-011 and a postoperative non-opioid multimodal analgesic (MMA) regimen. The study will be conducted in 2 …
Phase: PHASE3 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Could a low protein diet keep kidneys working longer?
Disease control Recruiting nowNephrology care continues to progress and recommendations are now focused on delaying as much as possible the need for renal replacement therapy ("intent-to-defer"strategy). Protein restriction is a valuable tool for stabilizing chronic kidney disease (CKD) and retarding the need…
Phase: NA • Sponsor: Centre Hospitalier le Mans • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug bimekizumab shows promise for psoriatic arthritis in phase 3 trial
Disease control CompletedThis is a study to demonstrate the clinical efficacy, safety and tolerability of bimekizumab administered subcutaneously (sc) compared with placebo in the treatment of tumor necrosis factor alpha-inadequate responders (TNFα-IR) subjects with active Psoriatic Arthritis (PsA).
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Eye implant could offer long-term pressure control for glaucoma patients
Disease control CompletedThis study will evaluate the long-term safety and efficacy of Bimatoprost Sustained Release (SR) in patients with open-angle glaucoma or ocular hypertension who completed 1 of the 4 Phase 3 Bimatoprost SR studies (192024-091, -092, -093, or -095) and received Bimatoprost SR or wh…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New drug cocktail shows promise for tough head and neck cancers
Disease control CompletedThis proof-of-concept study aims to assess the clinical and biological effects of Atezolizumab combined with Bevacizumab in advanced previously treated squamous-cell carcinoma of the head and neck (HNSCC).
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Gene study aims to boost kidney transplant success for african americans
Knowledge-focused OngoingThe APOLLO study is being done in an attempt to improve outcomes after kidney transplantation and to improve the safety of living kidney donation based upon variation in the apolipoprotein L1 gene (APOL1). Genes control what is inherited from a family, such as eye color or blood …
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New anthrax vaccine shows promise in large trial
⭐️ VACCINE ⭐️ CompletedThis study is designed to evaluate the lot consistency (using three consecutively manufactured lots), safety, and ability of the AV7909 anthrax vaccine to generate an immune response in healthy adults and compare the response to that induced by the currently licensed vaccine, Bio…
Phase: PHASE3 • Sponsor: Emergent BioSolutions • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:29 UTC